HR 328 · 109th Congress 2005–2007, ended

Pharmaceutical Market Access Act of 2005

Latest action · Jun 21, 2005 Sponsor introductory remarks on measure. (CR H4861)

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedJan 25, 2005
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Pharmaceutical Market Access Act of 2005 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to promulgate regulations permitting pharmacists, pharmacies, wholesalers, and individuals to import qualifying drugs from certain countries into the United States.

Sets forth registration requirements for exporters.

Requires the Secretary to: (1) educate consumers with regard to the availability of qualifying drugs for import for personal use; (2) inspect the facilities and records of importers and registered exporters to ensure compliance with this Act; and (3) establish a registration fee program to collect an annual fee from registered exporters.

Deems a prescription drug to be misbranded unless the packaging of such drug complies with the requirements for counterfeit-resistant technologies.

Prohibits: (1) failing to register in accordance with this Act; and (2) importing or offering to import a prescription drug in violation of a suspension order.

Declares that selling or importing a patented drug in the United States that was first sold abroad by or under authority of the owner or licensee of the patent is not patent infringement.

Prohibits drug manufacturers from discriminating against a person that engages in the importation of a prescription drug, including by charging higher prices or denying supplies of the drug.

Allows the Secretary to suspend or terminate the registration of an exporter for failing to maintain substantial compliance with all registration conditions.

Cosponsors 121

Members who signed on, in the order they did. Signatures ran from Jan 25, 2005 to Jul 27, 2006; 14 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
R-KYAnne M. NorthupOriginalJan 25, 2005
I-VTBernard SandersOriginalJan 25, 2005
R-INDan BurtonOriginalJan 25, 2005
R-OKErnest J. Istook Jr.OriginalJan 25, 2005
R-FLGinny Brown-WaiteOriginalJan 25, 2005
R-GAJack KingstonOriginalJan 25, 2005
D-RIJames R. LangevinOriginalJan 25, 2005
R-MNJim RamstadOriginalJan 25, 2005
R-MOJo Ann EmersonOriginalJan 25, 2005
D-ILRahm EmanuelOriginalJan 25, 2005
D-CTRosa L. DeLauroOriginalJan 25, 2005
D-OHSherrod BrownOriginalJan 25, 2005
R-IASteve KingOriginalJan 25, 2005
R-NCWalter B. JonesOriginalJan 25, 2005
D-MABarney FrankFeb 1, 2005

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Jan 25, 2005
Health Subcommittee
Referred Feb 25, 2005
HouseJudiciary Committee
Referred Jan 25, 2005
Courts, Intellectual Property, Artificial Intelligence, and the Internet Subcommittee
Referred Mar 3, 2005

Actions 11

Everything that happened, newest first.

  1. Jun 21, 2005Sponsor introductory remarks on measure. (CR H4861)
  2. Jun 20, 2005Sponsor introductory remarks on measure. (CR H4784-4785)
  3. May 17, 2005Sponsor introductory remarks on measure. (CR H3406-3407)
  4. May 16, 2005Sponsor introductory remarks on measure. (CR H3289-3290)
  5. Apr 13, 2005Sponsor introductory remarks on measure. (CR H1945-1946)
  6. Apr 5, 2005Sponsor introductory remarks on measure. (CR H1754)
  7. Mar 2, 2005Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.
  8. Feb 25, 2005Referred to the Subcommittee on Health.
  9. Feb 15, 2005Sponsor introductory remarks on measure. (CR H606)
  10. Jan 25, 2005Introduced in House
  11. Jan 25, 2005Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

In the Congressional Record 5

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
HouseDebate and remarks H9934Marcy Kaptur D-OHNov 7, 2005
HouseDebate and remarks H4861—Jun 21, 2005
HouseDebate and remarks H4373Gil Gutknecht R-MNJun 13, 2005
HouseDebate and remarks H3289Gil Gutknecht R-MNMay 16, 2005
HouseDebate and remarks H1945, H1947Gil Gutknecht R-MN, Rahm Emanuel D-ILApr 13, 2005

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Printed hearings 1

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
S. Hrg. 109-70DRUG IMPORTATION: THE REALITIES OF SAFETY AND SECURITY65 pagesHealth, Education, Labor, and Pensions CommitteeFeb 16, 2005

CRS reports 2

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

Cite it 2

Products on other subjects that cite it, usually among other measures.

Related bills 2

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 109Pharmaceutical Market Access Act of 2005Related billJan 24, 2005
HR 4792Fix Medicare Part D ActRelated billFeb 17, 2006

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes.
Short Titles as Introduced
Pharmaceutical Market Access Act of 2005

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Jan 25, 2005Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.